Upload Avatar (500 x 500)
Hu Zhiming
Laboratory Medicine and Biotechnology
Southern Medical University
Guangdong
Language: Chinese, English
Regulatory T Cells
Immune Regulation
Mechanism
Tumor
Immunotherapy
Cancer
Vaccine
Cellular Immunity
Therapeutics
Research
Areas of Focus
- Regulatory T Cell Immune Regulation Mechanism
- Tumor Immunotherapy
Academic Background & Achievements
- 1985.9-1988.7: Medical Experimental Technology, First Military Medical University
- 1994.9-1997.7: Master's in Immunology, First Military Medical University
- 2002.9-2005.7: PhD in Immunology, First Military Medical University
Publications
- Norcantharidin enhances antitumor immunity of GM-CSF prostate cancer cells vaccine by inducing apoptosis of regulatory T cells., Mo L, Zhang X, Shi X, Wei L, Zheng D, Li H, Gao J, Li J, Hu Z, 2018
- ICOS signal facilitates Foxp3 transcription to favor suppressive function of regulatory T cells., Chen Q, Mo L, Cai X, Wei L, Xie Z, Li H, Li J, Hu Z, 2018
- Depletion of regulatory T cells by anti-ICOS antibody enhances anti-tumor immunity of tumor cell vaccine in prostate cancer., Mo L, Chen Q, Zhang X, Shi X, Wei L, Zheng D, Li H, Gao J, Li J, Hu Z, 2017
- A novel immunotherapy for superficial bladder cancer by intravesical immobilization of GM-CSF., Hu Z, Tan W, Zhang L, Liang Z, Xu C, Su H, Lu J, Gao J, 2010
- Low-dose paclitaxel enhances the anti-tumor efficacy of GM-CSF surface-modified whole-tumor-cell vaccine in mouse model of prostate cancer., He Q, Li J, Yin W, Song Z, Zhang Z, Yi T, Tang J, Wu D, Lu Y, Wang Z, Liu D, Zhang X, Hu Z, Gao J, 2011
Awards
- 2013: Zhejiang Provincial Science and Technology Award, First Prize, Third Place
- 2012: Zhejiang Provincial Higher Education Outstanding Scientific Research Achievement Award, First Prize, Second Place
